What is Poseida Therapeutics?
Founded in 2014 and based in California, Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing novel gene therapies for patients with serious unmet medical needs, particularly in oncology and hematology. The company leverages its proprietary gene editing and delivery technologies to create advanced therapeutic candidates. Poseida's focus on complex diseases positions it within a critical segment of the biotechnology market, aiming to address challenging conditions where current treatments are insufficient.
How much funding has Poseida Therapeutics raised?
Poseida Therapeutics has raised a total of $566.3M across 8 funding rounds:
Series A
$23M
Private Equity
$11.2M
Unspecified
$19.8M
Series B
$30.5M
Series C
$142M
Series D
$110M
Stock Offering
$204.8M
Share Placement
$25M
Series A (2015): $23M with participation from Malin Corporation Plc
Private Equity (2017): $11.2M, investors not publicly disclosed
Unspecified (2017): $19.8M supported by California Institute of Regenerative Medicine
Series B (2018): $30.5M featuring Longitude Capital, Malin Corporation plc, Tavistock Life Sciences, and Vivo Capital
Series C (2019): $142M backed by Boxer Capital, Longitude Capital, Malin Corporation plc, Vivo Capital, Perceptive Advisors, Novartis Pharma, Aisling Capital, and Pentwater Capital Management
Series D (2020): $110M with participation from Fidelity Management Research Company, Schonfeld Strategic Advisors, and Adage Capital Management
Stock Issuance/Offering (2020): $204.8M, investors not publicly disclosed
Share Placement (2023): $25M supported by Astellas Venture Management
Key Investors in Poseida Therapeutics
Boxer Capital
Boxer Capital, LLC, is a private investment fund that invests in biotechnology drug development across multiple therapeutic indications, often focusing on early-stage companies.
Longitude Capital
Longitude Capital is a healthcare-focused venture capital firm that invests in biotechnology, medical technology, and health solutions companies, providing both capital and strategic partnership.
Malin Corporation plc
Malin Corporation plc is an investment company with a focus on the life sciences sector, providing capital and strategic support to innovative healthcare companies.
What's next for Poseida Therapeutics?
The recent major strategic investment in Poseida Therapeutics signals a pivotal moment for the company, likely enabling accelerated development of its pipeline candidates and expansion of its research and manufacturing capabilities. This infusion of capital is expected to support the progression of its gene therapy programs through clinical trials and towards potential commercialization. The company's strategic focus on high-unmet-need areas suggests a continued emphasis on innovation and scientific advancement in the competitive biopharmaceutical landscape.
See full Poseida Therapeutics company page
